-
Product Insights
NewDipeptidyl Peptidase 4 – Drugs In Development, 2024
The Dipeptidyl Peptidase 4 pipeline drugs market research report outlays comprehensive information on the Dipeptidyl Peptidase 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, Ophthalmology, and Undisclosed which include indications of Type 2 Diabetes, Diabetes, Cardiovascular Disease, Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD), Diabetic Retinopathy, Glaucoma, and Unspecified. It also reviews...
-
Product Insights
NewTryptophan 2,3 Dioxygenase – Drugs In Development, 2024
The Tryptophan 2,3 Dioxygenase pipeline drugs market research report outlays comprehensive information on the Tryptophan 2,3 Dioxygenase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Genito Urinary System, and Central Nervous System which include indications of Oncology, Solid Tumor, End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), and Parkinson's Disease. It also reviews key players involved...
-
Product Insights
NewDiacylglycerol O Acyltransferase – Drugs In Development, 2024
The Diacylglycerol O Acyltransferase pipeline drugs market research report outlays comprehensive information on the Diacylglycerol O Acyltransferase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Metabolic Disorders, Dermatology, and Infectious Disease which include indications of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Hypertriglyceridemia, Obesity, Acne Vulgaris, and Coronavirus Disease 2019 (COVID-19). It also...
-
Product Insights
NewLymphotoxin Alpha – Drugs In Development, 2024
The Lymphotoxin Alpha pipeline drugs market research report outlays comprehensive information on the Lymphotoxin Alpha targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Musculoskeletal Disorders, Gastrointestinal, and Infectious Disease which include indications of Rheumatoid Arthritis, Plaque Psoriasis (Psoriasis Vulgaris), Ankylosing Spondylitis (Bekhterev's Disease), Psoriatic Arthritis, Ulcerative Colitis, and Coronavirus Disease 2019 (COVID-19). It also reviews key...
-
Product Insights
NewHepatitis A Virus Cellular Receptor 2 – Drugs In Development, 2024
The Hepatitis A Virus Cellular Receptor 2 pipeline drugs market research report outlays comprehensive information on the Hepatitis A Virus Cellular Receptor 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Infectious Disease, Immunology, and Dermatology which include indications of Solid Tumor, Unspecified Cancer, Infectious Disease, Coronavirus Disease 2019 (COVID-19) Pneumonia, Rheumatoid Arthritis, and Hidradenitis Suppurativa....
-
Product Insights
NewRibonucleoside Diphosphate Reductase – Drugs In Development, 2024
The Ribonucleoside Diphosphate Reductase pipeline drugs market research report outlays comprehensive information on the Ribonucleoside Diphosphate Reductase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Hematological Disorders, Central Nervous System, and Infectious Disease which include indications of Pancreatic Cancer, Solid Tumor, Sickle Cell Disease, Multiple Sclerosis, Encephalomyelitis, Infectious Disease, and Unspecified Bacterial Infections. It also reviews...
-
Product Insights
NewSuperoxide Dismutase – Drugs In Development, 2024
The Superoxide Dismutase pipeline drugs market research report outlays comprehensive information on the Superoxide Dismutase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Infectious Disease, and Toxicology which include indications of Amyotrophic Lateral Sclerosis, Neurodegenerative Diseases, Leishmaniasis (Kala-Azar), Chagas Disease (American Trypanosomiasis), and Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome). It also reviews key...
-
Product Insights
NewHepatocyte Growth Factor – Drugs In Development, 2024
The Hepatocyte Growth Factor pipeline drugs market research report outlays comprehensive information on the Hepatocyte Growth Factor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Oncology, Cardiovascular, and Gastrointestinal which include indications of Amyotrophic Lateral Sclerosis, Diabetic Peripheral Neuropathy, Oncology, Ovarian Cancer, Coronary Artery Disease (CAD) (Ischemic Heart Disease), Peripheral Arterial Disease (PAD)/ Peripheral...
-
Product Insights
NewNT 3 Growth Factor Receptor – Drugs In Development, 2024
The NT 3 Growth Factor Receptor pipeline drugs market research report outlays comprehensive information on the NT 3 Growth Factor Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Genetic Disorders, and Hematological Disorders which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Alzheimer's Disease, Parkinson's Disease, Letterer-Siwe Disease (Multifocal and multisystemic...
-
Product Insights
NewNeutrophil Elastase – Drugs In Development, 2024
The Neutrophil Elastase pipeline drugs market research report outlays comprehensive information on the Neutrophil Elastase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Immunology, Genetic Disorders, and Infectious Disease which include indications of Respiratory, Unspecified Respiratory Disorders, Inflammation, Graft Versus Host Disease (GVHD), Alpha-1 Antitrypsin Deficiency (A1AD), Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair), Infectious Disease, and...